Tags

Type your tag names separated by a space and hit enter

Antidementia drug prescription sources and patterns after the diagnosis of dementia in Germany: results of a claims data-based 1-year follow-up.
Int Clin Psychopharmacol. 2011 Jul; 26(4):225-31.IC

Abstract

We examined the patterns of prescription for antidementia drugs by German physicians with special reference to source of prescription, appropriateness of drugs and dosages and continuity of prescription patterns. The study is based on claims data of all 1848 incident cases in persons aged 65 years and older from a nationwide operating statutory health insurance company in the years 2004-2006. Inclusion criteria were one International Statistical Classification of Diseases and Related Health Problems 10th Revision code for dementia in at least three of four consecutive quarters and four quarters without such a code beforehand. Defined daily doses were used to quantify the prescription size. Data analysis used univariate and multivariate techniques. The majority of incident dementia cases in general and Alzheimer's disease cases in particular did not receive medication in conformity with the guidelines during the year after incidence. Inappropriate prescription was related to not visiting a specialist, living in urban areas, age and comorbidity. Further research is needed both on reasons for nonprescription among professionals and for discontinuation by the patients. In addition, the problems of practicability and implementation of guidelines deserve more attention.

Authors+Show Affiliations

Institute of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Germany. bussche@uke.deNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

21394033

Citation

van den Bussche, Hendrik, et al. "Antidementia Drug Prescription Sources and Patterns After the Diagnosis of Dementia in Germany: Results of a Claims Data-based 1-year Follow-up." International Clinical Psychopharmacology, vol. 26, no. 4, 2011, pp. 225-31.
van den Bussche H, Kaduszkiewicz H, Koller D, et al. Antidementia drug prescription sources and patterns after the diagnosis of dementia in Germany: results of a claims data-based 1-year follow-up. Int Clin Psychopharmacol. 2011;26(4):225-31.
van den Bussche, H., Kaduszkiewicz, H., Koller, D., Eisele, M., Steinmann, S., Glaeske, G., & Wiese, B. (2011). Antidementia drug prescription sources and patterns after the diagnosis of dementia in Germany: results of a claims data-based 1-year follow-up. International Clinical Psychopharmacology, 26(4), 225-31. https://doi.org/10.1097/YIC.0b013e328344c600
van den Bussche H, et al. Antidementia Drug Prescription Sources and Patterns After the Diagnosis of Dementia in Germany: Results of a Claims Data-based 1-year Follow-up. Int Clin Psychopharmacol. 2011;26(4):225-31. PubMed PMID: 21394033.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Antidementia drug prescription sources and patterns after the diagnosis of dementia in Germany: results of a claims data-based 1-year follow-up. AU - van den Bussche,Hendrik, AU - Kaduszkiewicz,Hanna, AU - Koller,Daniela, AU - Eisele,Marion, AU - Steinmann,Susanne, AU - Glaeske,Gerd, AU - Wiese,Birgitt, PY - 2011/3/12/entrez PY - 2011/3/12/pubmed PY - 2012/2/3/medline SP - 225 EP - 31 JF - International clinical psychopharmacology JO - Int Clin Psychopharmacol VL - 26 IS - 4 N2 - We examined the patterns of prescription for antidementia drugs by German physicians with special reference to source of prescription, appropriateness of drugs and dosages and continuity of prescription patterns. The study is based on claims data of all 1848 incident cases in persons aged 65 years and older from a nationwide operating statutory health insurance company in the years 2004-2006. Inclusion criteria were one International Statistical Classification of Diseases and Related Health Problems 10th Revision code for dementia in at least three of four consecutive quarters and four quarters without such a code beforehand. Defined daily doses were used to quantify the prescription size. Data analysis used univariate and multivariate techniques. The majority of incident dementia cases in general and Alzheimer's disease cases in particular did not receive medication in conformity with the guidelines during the year after incidence. Inappropriate prescription was related to not visiting a specialist, living in urban areas, age and comorbidity. Further research is needed both on reasons for nonprescription among professionals and for discontinuation by the patients. In addition, the problems of practicability and implementation of guidelines deserve more attention. SN - 1473-5857 UR - https://www.unboundmedicine.com/medline/citation/21394033/Antidementia_drug_prescription_sources_and_patterns_after_the_diagnosis_of_dementia_in_Germany:_results_of_a_claims_data_based_1_year_follow_up_ L2 - http://dx.doi.org/10.1097/YIC.0b013e328344c600 DB - PRIME DP - Unbound Medicine ER -